Literature DB >> 15656809

Thick melanoma: the challenge persists.

C S Murray1, D L Stockton, V R Doherty.   

Abstract

BACKGROUND: Considerable resources have been channelled into primary and secondary prevention of cutaneous melanoma over the past 20 years. These efforts have been associated with a significant increase in the proportion of thin, good prognosis lesions and this is felt to be the principal reason for the current overall improvement in melanoma survival.
OBJECTIVES: Analysis of Scottish Melanoma Group (SMG) data was carried out to identify the proportion of thick melanomas presenting over time. SMG data were used to characterize the patients presenting with thick melanoma.
METHODS: Using data from the SMG database 915 patients (392 male and 523 female) first diagnosed with invasive melanoma > or = 3.5 mm thick in the two decades between 1979 and 1998, inclusive, were identified. The patients were from regions designated South-east Scotland, Tayside, Grampian and Highland, which together form half of all Scottish cases.
RESULTS: The analysis shows that, although the proportion of thick, poor prognosis melanomas has decreased over time, the number presenting per year has not significantly altered. In the first decade, 50.5% of registrations were thick lesions and these fell to 31.0% in the second decade. In the first decade there were 419 cases (173 male), median age 66 years (range 5-99). Fifty-five patients were under the age of 40 years. Two hundred and twelve melanomas were nodular, 116 superficial spreading (SSM), 34 acral and 26 lentigo maligna melanoma. Sixty-nine patients had either lymph node involvement or distant spread at presentation. Despite a 93.3% increase in the total number of melanoma registrations by the end of the second decade, there was relatively little change in the absolute numbers of thick lesions. The total number of thick lesions was 496 (220 male), an increase of 18.4%. Median age was greater, at 70 years (range 1-98), and 31 patients were under the age of 40 years. Nodular was still the commonest type but its proportion had dropped significantly compared with the first decade, with a corresponding increase in SSM and acral types.
CONCLUSIONS: Over a 20-year period there was little change in the absolute number of patients presenting with thick melanoma each year, though these form a diminishing proportion of the rising number of total melanomas. This thick melanoma group is characterized by an increasingly older age group and a changing type profile, nodular and SSM being the most common types. This work suggests that the resources currently directed at public and professional education on melanoma are having no effect on this group of patients and that alternative strategies may need to be considered.

Entities:  

Mesh:

Year:  2005        PMID: 15656809     DOI: 10.1111/j.1365-2133.2005.06409.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

Authors:  Erin X Wei; Abrar A Qureshi; Jiali Han; Tricia Y Li; Eunyoung Cho; Jennifer Y Lin; Wen-Qing Li
Journal:  J Am Acad Dermatol       Date:  2016-07-16       Impact factor: 11.527

2.  Increased C-MYC copy numbers on the background of CDKN2A loss is associated with improved survival in nodular melanoma.

Authors:  Denitsa Koynova; Ekaterina Jordanova; Nicole Kukutsch; Pieter van der Velden; Draga Toncheva; Nelleke Gruis
Journal:  J Cancer Res Clin Oncol       Date:  2006-09-15       Impact factor: 4.553

Review 3.  Epidemiology and treatment of melanoma in elderly patients.

Authors:  Susan Tsai; Charles Balch; Julie Lange
Journal:  Nat Rev Clin Oncol       Date:  2010-02-09       Impact factor: 66.675

4.  Prevention of malignant melanoma.

Authors:  G Chaidemenos; A Stratigos; M Papakonstantinou; F Tsatsou
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

5.  Mitochondrial haplogroups, control region polymorphisms and malignant melanoma: a study in middle European Caucasians.

Authors:  Sabine Ebner; Roland Lang; Edith E Mueller; Waltraud Eder; Michaela Oeller; Alexandra Moser; Josef Koller; Bernhard Paulweber; Johannes A Mayr; Wolfgang Sperl; Barbara Kofler
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

6.  Phenotypic Characteristics and Melanoma Thickness in Women.

Authors:  Reza Ghiasvand; Adèle C Green; Torkjel M Sandanger; Elisabete Weiderpass; Trude E Robsahm; Marit B Veierød
Journal:  Acta Derm Venereol       Date:  2021-04-29       Impact factor: 3.875

7.  Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.

Authors:  A Downing; J A Newton-Bishop; D Forman
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

8.  Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma.

Authors:  Juan Carlos Rodriguez Otero; Maria Susana Dagatti; Ramon Fernandez Bussy; Adriana Bergero; Mario Gorosito; Roberto Staffieri; Roberto Villavicencio; Stella Maris Batalles; Stella Maris Pezzotto
Journal:  World J Oncol       Date:  2019-04-20

9.  Increasing melanoma awareness among health and social care professionals in secondary care in an era of reduced skin cancer referrals due to COVID-19.

Authors:  C Quinlan; R Gill; M Murphy
Journal:  Clin Exp Dermatol       Date:  2020-07-22       Impact factor: 4.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.